bupropion and Cardiovascular Diseases

bupropion has been researched along with Cardiovascular Diseases in 49 studies

Research

Studies (49)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (6.12)	18.7374
1990's	1 (2.04)	18.2507
2000's	13 (26.53)	29.6817
2010's	30 (61.22)	24.3611
2020's	2 (4.08)	2.80

Authors

Authors	Studies
Choi, SKY; Chow, CK; Filion, KB; Havard, A; Pearson, SA; Tran, DT	1
Bassett, K; Carney, G; Dormuth, CR; Maclure, M; Taylor, S	1
Kotz, D; Sheikh, A; Simpson, CR; van Schayck, OCP; Viechtbauer, W; West, R	1
Galanti, MR; Hansson, J; Janszky, I; Möller, J; Monárrez-Espino, J; Söderberg-Löfdal, K	1
Ascher, J; Hasselblad, V; Huang, M; Kittle, J; Kolls, BJ; Krishen, A; Lopes, RD; Mahaffey, KW; Marquess, ML; McGuire, DK; Roe, MT; Russell, SD; Wilson, MD	1
Anthenelli, RM; Benowitz, NL; Hays, JT; Lawrence, D; McRae, T; Pipe, A; St Aubin, L; Tonstad, S; West, R	1
Apovian, CM; Aronne, L; Burns, C; Dunayevich, E; Kim, D; Rubino, D; Still, C; Wyatt, H	1
Baker, MA; Brown, JS; Kornegay, C; Platt, R; Toh, S	1
Clair, C; Rigotti, NA	1
Boomershine, V; Haber, SL; Raney, E	1
Poland, RE; Rao, U; Schramm, PJ	1
Eisenberg, MJ; Grandi, SM; Shimony, A	1
Eapen, S; Mills, EJ; Prochaska, JJ; Thorlund, K; Wu, P	1
Kallikazaros, IE; Katsi, VK; Makris, T; Marketou, M; Stefanadis, CI; Tousoulis, D; Vamvakou, G; Vardas, P	1
By, K; Graham, DJ; Kelman, JA; Kornegay, C; Levenson, M; MaCurdy, TE; McKean, S; Mosholder, A; Racoosin, JA; Worrall, C; Young, J	1
Cunningham, JW; Wiviott, SD	1
Azrin, ST; Baller, J; Daumit, GL; Juliano-Bult, D; McGinty, EE	1
Kotz, D; Sheikh, A; Simpson, C; van Schayck, OC; Viechtbauer, W; West, R	1
Abe, TO; Gaya, PV; Pereira, AC; Pinheiro, GG; Santos, PC; Scholz, J; Silva, AP	1
Psaty, BM; Sharfstein, JM	1
Bakris, G; Buse, JB; Nissen, SE; Perez, A; Prcela, L; Smith, SR; Wadden, T; Wolski, KE	1
Lewis, RJ; Tolles, J	1
Wise, J	1
Eberg, M; Eisenberg, MJ; Filion, KB; Gore, GC; Grad, R; Joseph, L; Larivière, J; Reynier, PM; Suissa, K	1
Bredesen, H; Lous, J	1
Hébert, R	1
Blum, LM; Eisenberg, MJ; Filion, KB; Gervais, A; Joseph, L; O'Loughlin, J; Paradis, G; Pilote, L; Rinfret, S	1
Ioannides-Demos, LL; McNeil, JJ; Piccenna, L	1
Astrup, A	1
Banasiak, W; Jankowski, P; Kawecka-Jaszcz, K; Musiał, J; Narkiewicz, K; Opolski, G; Podolec, P; Torbicki, A; Zatoński, W; Zembala, M	1
Cuesta, G; Lovato, P; Lutz, MA	1
Hviid, A; Pasternak, B; Svanström, H	1
Astbury, C; Farsang, C; Hider, A; Klaene, G; Lewis, K; Manolis, A; Perruchoud, AP; Silagy, C; Sweet, R; Tonstad, S; van Spiegel, PI	1
Richmond, R; Zwar, N	1
Bouvy, ML; Buurma, H; Egberts, AC	1
Alvarez, F; Botella-Carretero, JI; Cantarero, M; Escobar-Morreale, HF; García, G; Martín, I; Valero, AM; Varela, C	1
Fernández Pinilla, MC; Fernández-Cruz, A; Filozof, C	1
Cooke, CA; Sketris, IS; Whelan, AM	1
Cloutier, DA; Grollmes, TL; Hilleman, DE; Hunter, CB; Mohiuddin, SM; Mooss, AN	1
Bullen, C; Fagerström, K; McRobbie, H; Whittaker, R	1
de Oliveira, KU; Diament, J; Issa, JS; Perez, GH; Zavattieri, AG	1
Pipe, AL; Quinlan, B; Reid, RD; Riley, DL	1
Stern, WC; Wenger, TL	1
Glassman, AH; Preud'homme, XA	1
Hayes, PE; Kristoff, CA	1
Blaine, JD; Levine, J; Prien, RF	1

Reviews

18 review(s) available for bupropion and Cardiovascular Diseases

Article	Year
Managing tobacco use: the neglected cardiovascular disease risk factor. European heart journal, 2013, Volume: 34, Issue:42 Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Counseling; Female; Health Promotion; Humans; Male; Nicotinic Agonists; Physician's Role; Quinoxalines; Risk Factors; Risk Reduction Behavior; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Smoke Pollution; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline	2013
Safety of varenicline in patients with cardiovascular disease. Journal of pharmacy practice, 2014, Volume: 27, Issue:1 Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Risk; Smoking; Smoking Cessation; Smoking Prevention; Varenicline	2014
Bupropion for smoking cessation in patients hospitalized with cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials. The Canadian journal of cardiology, 2013, Volume: 29, Issue:12 Topics: Acute Coronary Syndrome; Adult; Aged; Bupropion; Cardiovascular Diseases; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Patient Outcome Assessment; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation	2013
Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Circulation, 2014, Jan-07, Volume: 129, Issue:1 Topics: Adult; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking; Smoking Cessation; Varenicline	2014
Novel antidepressant drugs, arterial hypertension and cardiovascular disease. Recent patents on cardiovascular drug discovery, 2013, Volume: 8, Issue:3 Topics: Animals; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Cardiovascular System; Cyclohexanols; Humans; Hypertension; Patents as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2013
Modern obesity pharmacotherapy: weighing cardiovascular risk and benefit. Clinical cardiology, 2014, Volume: 37, Issue:11 Topics: Anti-Obesity Agents; Benzazepines; Bupropion; Cardiovascular Diseases; Clinical Trials as Topic; Drug Combinations; Fructose; Heart; Humans; Naltrexone; Obesity; Phentermine; Topiramate	2014
Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review. Schizophrenia bulletin, 2016, Volume: 42, Issue:1 Topics: Behavior Therapy; Bipolar Disorder; Bupropion; Cardiovascular Diseases; Diabetes Mellitus; Dopamine Uptake Inhibitors; Health Behavior; HIV Infections; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Metformin; Motor Activity; Nicotinic Agonists; Obesity; Overweight; Risk Reduction Behavior; Schizophrenia; Smoking; Smoking Cessation; Varenicline	2016
Cardiac adverse effects of nicotine replacement therapy. Prescrire international, 2015, Volume: 24, Issue:166 Topics: Bupropion; Cardiovascular Diseases; Humans; Tobacco Use Cessation Devices; Varenicline	2015
Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials. Circulation. Cardiovascular quality and outcomes, 2017, Volume: 10, Issue:1 Topics: Bupropion; Cardiovascular Diseases; Counseling; Humans; Network Meta-Analysis; Nicotinic Agonists; Odds Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Varenicline	2017
The efficacy of smoking cessation therapies in cardiac patients: a meta-analysis of randomized controlled trials. The Canadian journal of cardiology, 2010, Volume: 26, Issue:2 Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Cardiovascular Diseases; Humans; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Treatment Outcome	2010
Smoking cessation-recent advances. Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:4 Topics: Australia; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Humans; Immunotherapy, Active; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Transdermal Patch; Treatment Outcome; United Kingdom; United States; Varenicline	2010
Review of bupropion for smoking cessation. Drug and alcohol review, 2003, Volume: 22, Issue:2 Topics: Antidepressive Agents, Second-Generation; Bupropion; Cardiovascular Diseases; Delayed-Action Preparations; Depression; Dopamine; Humans; Impulsive Behavior; Norepinephrine; Pulmonary Disease, Chronic Obstructive; Recurrence; Smoking; Smoking Cessation; Tobacco Use Disorder	2003
Smoking cessation and weight gain. Obesity reviews : an official journal of the International Association for the Study of Obesity, 2004, Volume: 5, Issue:2 Topics: Body Composition; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Female; Humans; Insulin Resistance; Nicotine; Obesity; Randomized Controlled Trials as Topic; Risk Factors; Smoking Cessation; Weight Gain	2004
A clinical imperative: assisting patients who smoke to reduce their risk of cardiovascular disease. Preventive cardiology, 2007,Spring, Volume: 10, Issue:2 Suppl 1 Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Directive Counseling; Hospitalization; Humans; Neurotransmitter Uptake Inhibitors; Nicotinic Agonists; Nortriptyline; Quinoxalines; Referral and Consultation; Risk Reduction Behavior; Smoking; Smoking Cessation; Varenicline	2007
Smoking cessation: lessons learned from clinical trial evidence. Current opinion in cardiology, 2007, Volume: 22, Issue:4 Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Varenicline	2007
The cardiovascular profile of bupropion. The Journal of clinical psychiatry, 1983, Volume: 44, Issue:5 Pt 2 Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Blood Pressure; Bupropion; Cardiovascular Diseases; Cardiovascular System; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Electrocardiography; Female; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Propiophenones	1983
Review of the cardiovascular effects of heterocyclic antidepressants. The Journal of clinical psychiatry, 1993, Volume: 54 Suppl Topics: Amoxapine; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Bupropion; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Cardiovascular System; Depressive Disorder; Heart; Humans; Hypotension, Orthostatic; Maprotiline; Selective Serotonin Reuptake Inhibitors; Trazodone	1993
Adverse reactions to five new antidepressants. Clinical pharmacy, 1986, Volume: 5, Issue:6 Topics: Acute Kidney Injury; Amoxapine; Animals; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Dopamine Antagonists; Humans; Male; Maprotiline; Nomifensine; Priapism; Propiophenones; Seizures; Trazodone	1986

Trials

8 trial(s) available for bupropion and Cardiovascular Diseases

Article	Year
Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial. JAMA internal medicine, 2018, 05-01, Volume: 178, Issue:5 Topics: Bupropion; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Outcome Assessment, Health Care; Risk Factors; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline	2018
A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring, Md.), 2013, Volume: 21, Issue:5 Topics: Adult; Anti-Obesity Agents; Bupropion; Cardiovascular Diseases; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Feeding Behavior; Female; Humans; Hypertension; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Obesity; Overweight; Quality of Life; Risk Factors; Weight Loss	2013
Bupropion response on sleep quality in patients with depression: implications for increased cardiovascular disease risk. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2014, Volume: 24, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cardiovascular Diseases; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Electrocardiography; Female; Heart; Heart Rate; Humans; Male; Polysomnography; Risk; Sleep; Sleep Stages; Sleep, REM; Time Factors	2014
Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial. JAMA, 2016, Mar-08, Volume: 315, Issue:10 Topics: Aged; Anti-Obesity Agents; Blood Pressure; Body Mass Index; Bupropion; Cardiovascular Diseases; Confidence Intervals; Confidentiality; Double-Blind Method; Drug Therapy, Combination; Early Termination of Clinical Trials; Female; Humans; Internet; Male; Middle Aged; Myocardial Infarction; Naltrexone; Obesity; Overweight; Patient Selection; Placebo Effect; Risk Factors; Sample Size; United States; Weight Reduction Programs	2016
Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. European heart journal, 2003, Volume: 24, Issue:10 Topics: Adult; Aged; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome	2003
Weight gain and cardiovascular risk factors during smoking cessation with bupropion or nicotine. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2004, Volume: 36, Issue:3 Topics: Administration, Cutaneous; Adult; Aging; Blood Pressure; Bupropion; Cardiovascular Diseases; Diastole; Female; Humans; Insulin Resistance; Lipids; Male; Middle Aged; Nicotine; Nicotinic Agonists; Obesity; Risk Factors; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Thinness; Weight Gain	2004
Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest, 2007, Volume: 131, Issue:2 Topics: Adult; Aged; Behavior Therapy; Bupropion; Cardiovascular Diseases; Directive Counseling; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Smoking Cessation; Treatment Outcome	2007
The cardiovascular profile of bupropion. The Journal of clinical psychiatry, 1983, Volume: 44, Issue:5 Pt 2 Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Blood Pressure; Bupropion; Cardiovascular Diseases; Cardiovascular System; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Electrocardiography; Female; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Propiophenones	1983

Other Studies

24 other study(ies) available for bupropion and Cardiovascular Diseases

Article	Year
Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia. JAMA network open, 2021, 11-01, Volume: 4, Issue:11 Topics: Adult; Bupropion; Cardiovascular Diseases; Cohort Studies; Female; Humans; Male; Middle Aged; New South Wales; Retrospective Studies; Smoking; Smoking Cessation Agents; Varenicline	2021
Cardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non-depressed adults: a retrospective cohort study. Addiction (Abingdon, England), 2020, Volume: 115, Issue:8 Topics: Adolescent; Adult; Aged; Bupropion; Cardiovascular Diseases; Cohort Studies; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Retrospective Studies; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline; Young Adult	2020
Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease. Thorax, 2017, Volume: 72, Issue:10 Topics: Adult; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; England; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Propensity Score; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Risk Factors; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2017
Treatment With Bupropion and Varenicline for Smoking Cessation and the Risk of Acute Cardiovascular Events and Injuries: a Swedish Case-Crossover Study. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2018, 04-02, Volume: 20, Issue:5 Topics: Accidental Falls; Accidents, Traffic; Adult; Bupropion; Cardiovascular Diseases; Cross-Over Studies; Humans; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome; Suicide, Attempted; Sweden; Tobacco Use Disorder; Varenicline; Wounds and Injuries	2018
Cardiovascular adverse events in the drug-development program of bupropion for smoking cessation: A systematic retrospective adjudication effort. Clinical cardiology, 2017, Volume: 40, Issue:10 Topics: Adult; Bupropion; Cardiotoxicity; Cardiovascular Diseases; Drug Discovery; Female; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Smoking Cessation; Stroke; Time Factors; Treatment Outcome	2017
Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. JAMA internal medicine, 2013, May-13, Volume: 173, Issue:9 Topics: Adult; Aged; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Prescriptions; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Risk Assessment; Risk Factors; Sentinel Surveillance; Smoking Cessation; Tobacco Use Disorder; United States; United States Food and Drug Administration; Varenicline	2013
Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study. Pharmacoepidemiology and drug safety, 2014, Volume: 23, Issue:11 Topics: Aged; Aged, 80 and over; Benzazepines; Bupropion; Cardiovascular Diseases; Cohort Studies; Comorbidity; Female; Humans; Incidence; Male; Medicare; Nicotinic Agonists; Quinoxalines; Smoking Cessation; United States; Varenicline	2014
Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study. The Lancet. Respiratory medicine, 2015, Volume: 3, Issue:10 Topics: Adult; Bupropion; Cardiovascular Diseases; Depression; Dopamine Uptake Inhibitors; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2015
Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting. BMC cardiovascular disorders, 2016, Jan-05, Volume: 16 Topics: Adult; Aged; Blood Pressure; Brazil; Bupropion; Cardiovascular Diseases; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Diastole; Dopamine Uptake Inhibitors; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nicotine; Nicotinic Agonists; Risk Factors; Smoking; Smoking Cessation; Systole; Tobacco Use Cessation Devices; Varenicline	2016
Evaluation of the Cardiovascular Risk of Naltrexone-Bupropion: A Study Interrupted. JAMA, 2016, Mar-08, Volume: 315, Issue:10 Topics: Anti-Obesity Agents; Bupropion; Cardiovascular Diseases; Early Termination of Clinical Trials; Female; Humans; Male; Naltrexone; Obesity	2016
Time-to-Event Analysis. JAMA, 2016, Mar-08, Volume: 315, Issue:10 Topics: Anti-Obesity Agents; Bupropion; Cardiovascular Diseases; Early Termination of Clinical Trials; Female; Humans; Male; Naltrexone; Obesity	2016
Company is blamed for early halt of trial into obesity treatment. BMJ (Clinical research ed.), 2016, Mar-08, Volume: 352 Topics: Anti-Obesity Agents; Bupropion; Cardiovascular Diseases; Early Termination of Clinical Trials; Female; Humans; Male; Naltrexone; Obesity	2016
[Smoking cessation with special focus on primary health care]. Ugeskrift for laeger, 2009, Feb-23, Volume: 171, Issue:9 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cardiovascular Diseases; Counseling; Evidence-Based Medicine; Family Practice; Humans; Nicotine; Nortriptyline; Outcome Assessment, Health Care; Primary Health Care; Psychotherapy, Group; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Smoking Prevention	2009
What's new in Nicotine & Tobacco Research? Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2009, Volume: 11, Issue:6 Topics: Advertising; Bupropion; Cardiovascular Diseases; Causality; Comorbidity; Dopamine Uptake Inhibitors; Global Health; Health Knowledge, Attitudes, Practice; Humans; Nicotine; Research Design; Smoking; Smoking Cessation; Tobacco Use Disorder	2009
Is cardiometabolic risk improved by weight-loss drugs? Lancet (London, England), 2010, Aug-21, Volume: 376, Issue:9741 Topics: Anti-Obesity Agents; Bupropion; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Naltrexone; Obesity; Risk Factors	2010
New obesity pill: new hopes, old fears. Lancet (London, England), 2010, Dec-18, Volume: 376, Issue:9758 Topics: Anti-Obesity Agents; Antidepressive Agents, Second-Generation; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Approval; Drug Combinations; Exercise; Feeding Behavior; Humans; Life Style; Naltrexone; Narcotic Antagonists; Obesity; Seizures; Suicidal Ideation; United States; United States Food and Drug Administration	2010
[Statement on the diagnosis and treatment of tobacco dependence in patients with cardiovascular diseases]. Kardiologia polska, 2011, Volume: 69, Issue:1 Topics: Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Humans; Patient Acceptance of Health Care; Poland; Smoking; Smoking Cessation; Tobacco Use Disorder	2011
Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model. Hospital practice (1995), 2012, Volume: 40, Issue:1 Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Central America; Cost-Benefit Analysis; Dominican Republic; Dopamine Uptake Inhibitors; Health Expenditures; Humans; Lung Neoplasms; Nicotinic Agonists; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2012
Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study. BMJ (Clinical research ed.), 2012, Nov-08, Volume: 345 Topics: Acute Coronary Syndrome; Adult; Age Distribution; Aged; Benzazepines; Bupropion; Cardiovascular Diseases; Cause of Death; Cohort Studies; Confidence Intervals; Denmark; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Quinoxalines; Retrospective Studies; Risk Assessment; Sex Distribution; Smoking Cessation; Stroke; Survival Analysis; Varenicline	2012
Determinants for successful smoking cessation with bupropion in daily practice. Pharmacy world & science : PWS, 2003, Volume: 25, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Bupropion; Cardiovascular Agents; Cardiovascular Diseases; Female; Follow-Up Studies; Humans; Male; Middle Aged; Netherlands; Pharmacists; Retrospective Studies; Smoking Cessation; Treatment Outcome	2003
Bupropion (amfebutamone): French pharmacovigilance data. Prescrire international, 2004, Volume: 13, Issue:70 Topics: Angioedema; Bupropion; Cardiovascular Diseases; France; Humans; Hypersensitivity; Seizures; Smoking Cessation; Suicide	2004
The impact of socioeconomic and demographic factors on the utilization of smoking cessation medications in patients hospitalized with cardiovascular disease in Nova Scotia, Canada. Journal of clinical pharmacy and therapeutics, 2005, Volume: 30, Issue:2 Topics: Administration, Cutaneous; Bupropion; Cardiovascular Diseases; Chewing Gum; Data Collection; Demography; Female; Hospitalization; Humans; Inpatients; Male; Middle Aged; Nicotine; Nova Scotia; Smoking; Smoking Cessation; Socioeconomic Factors; Time Factors	2005
Effectiveness of sustained-release bupropion in the treatment of smoker patients with cardiovascular disease. Arquivos brasileiros de cardiologia, 2007, Volume: 88, Issue:4 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Cardiovascular Diseases; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Smoking; Smoking Cessation; Treatment Outcome	2007
Antidepressant drug therapy: the role of the new antidepressants. Hospital & community psychiatry, 1985, Volume: 36, Issue:5 Topics: Amoxapine; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Depressive Disorder; Drug Evaluation; Humans; Legislation, Drug; Maprotiline; Propiophenones; Trazodone; United States	1985